Compile Data Set for Download or QSAR
maximum 50k data
Found 141 Enz. Inhib. hit(s) with Target = 'Sepiapterin reductase'
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50:  11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  12nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50:  19nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537670(CHEMBL4641380)
Affinity DataIC50:  20nMAssay Description:Tested for inhibition of cGMP-dependent protein kinase from bovine lungMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537669(CHEMBL4643608)
Affinity DataIC50:  20nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515168(CHEMBL4469291)
Affinity DataIC50:  30nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537671(CHEMBL4633843)
Affinity DataIC50:  30nMAssay Description:Tested for inhibition of cGMP-dependent protein kinase from bovine lungMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537646(CHEMBL512270)
Affinity DataIC50:  40nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515126(CHEMBL4451547)
Affinity DataIC50:  40nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537648(CHEMBL4640596)
Affinity DataIC50:  40nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537661(CHEMBL4648946)
Affinity DataIC50:  40nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537649(CHEMBL1723285)
Affinity DataIC50:  50nMAssay Description:Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537665(CHEMBL4648066)
Affinity DataIC50:  50nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537662(CHEMBL4647748)
Affinity DataIC50:  50nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537643(CHEMBL1506565)
Affinity DataIC50:  50nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515137(CHEMBL4476837)
Affinity DataIC50:  57nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537629(CHEMBL4635339)
Affinity DataIC50:  58nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50:  64nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537628(CHEMBL4643853)
Affinity DataIC50:  66nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537628(CHEMBL4643853)
Affinity DataIC50:  66.1nMAssay Description:Tested for inhibition of cGMP-dependent protein kinase from bovine lungMore data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50:  69nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537659(CHEMBL4646298)
Affinity DataIC50:  80nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537647(CHEMBL1403506)
Affinity DataIC50:  80nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515142(CHEMBL4460134)
Affinity DataIC50:  83nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50:  84nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50:  86nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515156(CHEMBL4542798)
Affinity DataIC50:  120nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537667(CHEMBL4639207)
Affinity DataIC50:  140nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537668(CHEMBL4647815)
Affinity DataIC50:  140nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537652(CHEMBL4640293)
Affinity DataIC50:  180nMAssay Description:Antagonist activity at CB1 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515170(CHEMBL4483803)
Affinity DataIC50:  210nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515183(CHEMBL4566276)
Affinity DataIC50:  240nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515153(CHEMBL4444034)
Affinity DataIC50:  280nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515125(CHEMBL4562659)
Affinity DataIC50:  290nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50:  310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50:  310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515123(CHEMBL4448911)
Affinity DataIC50:  310nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515154(CHEMBL4448675)
Affinity DataIC50:  310nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  310nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515161(CHEMBL4467218)
Affinity DataIC50:  310nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50537639(CHEMBL4639296)
Affinity DataIC50:  324nMAssay Description:Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cellsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50:  330nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50:  340nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515176(CHEMBL4567010)
Affinity DataIC50:  350nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50:  360nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515150(CHEMBL4437646)
Affinity DataIC50:  370nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515182(CHEMBL4456501)
Affinity DataIC50:  380nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50:  400nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM50515178(CHEMBL4449470)
Affinity DataIC50:  460nMAssay Description:Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 141 total ) | Next | Last >>
Jump to: